SCHEMBL7970842

SCHEMBL7970842

Cn1nc(-c2ccccc2)c(O)c1-c1nc2ccccc2[nH]1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 10/20 0.55
RAB9A P51151 9/20 0.55
GAA P10253 2/20 0.55
CA12 O43570 2/20 0.52
CA9 Q16790 2/20 0.52
KDM4E B2RXH2 9/20 0.50
SMN1; SMN2 Q16637 6/20 0.50
TP53 P04637 3/20 0.50
ALDH1A1 P00352 7/20 0.49
HTT P42858 3/20 0.49
CYP1A2 P05177 1/20 0.49
CYP3A4 P08684 1/20 0.49
CYP2C9 P11712 1/20 0.49
CYP2C19 P33261 1/20 0.49
PPARG P37231 1/20 0.49
NCOA2 Q15596 1/20 0.49
NCOA1 Q15788 1/20 0.49
NCOA3 Q9Y6Q9 1/20 0.49
HSD17B10 Q99714 3/20 0.49
NPSR1 Q6W5P4 3/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7976170 0.89 ITK (0.48) NPC1RAB9AGAACA12CA9
SCHEMBL10139808 0.89 P2RY6 (0.53) NPC1RAB9AGAACA12CA9
SCHEMBL10139885 0.86 MAPT (0.60) NPC1RAB9AGAAKDM4ESMN1; SMN2
SCHEMBL10139923 0.84 CBFB (0.50) NPC1RAB9AGAAKDM4ESMN1; SMN2
SCHEMBL7976986 0.84 CHEK2 (0.53) NPC1RAB9AKDM4ESMN1; SMN2ALDH1A1
SCHEMBL7982667 0.84 CHEK2 (0.52) P2RY6
SCHEMBL10140793 0.84 F9 (0.41) NPC1RAB9AGAACA12CA9
SCHEMBL10139913 0.84 F9 (0.43) NPC1RAB9AGAAKDM4ESMN1; SMN2
SCHEMBL7969435 0.83 CHEK2 (0.65)
SCHEMBL7971018 0.82 HSD17B10 (0.37) NPC1RAB9AGAACA12CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2805939-A1 Heterocyclic compounds as factor IXA inhibitors. Merck Sharp & Dohme Corp. (US) 2014-11-26 EP disclosed
WO-2009143039-A2 HETEROCYCLIC COMPOUNDS AS FACTOR IXA INHIBITORS SCHERING CORPORATION (US) 2009-11-26 WO disclosed